Stereotactic brain biopsy: Single center retrospective analysis of complications

Clinical Neurology and Neurosurgery

Volumn 111, Issue 10, 2009, Pages 835-839

  Chen, Ching Chang ^a   Hsu, Peng Wei ^a   Erich Wu, Tai Wei ^a   Lee, Shih Tseng ^a   Chang, Chen Nen ^a   Wei, Kuo chen ^a   Chuang, Chih Cheng ^a   Wu, Chieh Tsai ^a   Lui, Tai Ngar ^a   Hsu, Yung Hsin ^a   Lin, Tzu Kang ^a   Lee, Sai Cheung ^a   Huang, Yin Cheng ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Brain biopsy; Burr hole; Complication; Intracranial hemorrhage; Liver cirrhosis; Stereotactic procedure

Indexed keywords

ADULT; ARTICLE; BRAIN ABSCESS; BRAIN BIOPSY; BRAIN EDEMA; BRAIN HEMORRHAGE; CRANIOTOMY; DEBRIDEMENT; DIAGNOSTIC VALUE; FEMALE; HUMAN; HUMAN TISSUE; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PATIENT SAFETY; POSTOPERATIVE COMPLICATION; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE INFECTION; PREOPERATIVE PERIOD; RISK ASSESSMENT; SEIZURE; STEREOTACTIC BIOPSY; SUBARACHNOID HEMORRHAGE; SURGICAL MORTALITY; SURGICAL RISK; SURGICAL TECHNIQUE;

BIOPSY; BRAIN; BRAIN DISEASES; BRAIN NEOPLASMS; FEMALE; HUMANS; INTRACRANIAL HEMORRHAGES; LIVER CIRRHOSIS; MALE; MIDDLE AGED; NEUROSURGICAL PROCEDURES; RETROSPECTIVE STUDIES; RISK FACTORS; STEREOTAXIC TECHNIQUES; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 70350575269     PISSN: 03038467     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clineuro.2009.08.013     Document Type: Article

References (26)

1. Grossman R., Sadetzki S., Spiegelmann R., and Ram Z. Haemorrhagic complications and the incidence of asymptomatic bleeding associated with stereotactic brain biopsies. Acta Neurochir (Wien) 147 (2005) 627-631 [discussion 631]
2. Dammers R., Haitsma I.K., Schouten J.W., Kros J.M., Avezaat C.J., and Vincent A.J. Safety and efficacy of frameless and frame-based intracranial biopsy techniques. Acta Neurochir (Wien) 150 (2008) 23-29
3. Kreth F.W., Muacevic A., Medele R., Bise K., Meyer T., and Reulen H.J. The risk of haemorrhage after image guided stereotactic biopsy of intra-axial brain tumours-a prospective study. Acta Neurochir (Wien) 143 (2001) 539-545 [discussion 545-536]
4. Kulkarni A.V., Guha A., Lozano A., and Bernstein M. Incidence of silent hemorrhage and delayed deterioration after stereotactic brain biopsy. J Neurosurg 89 (1998) 31-35
5. Field M., Witham T.F., Flickinger J.C., Kondziolka D., and Lunsford L.D. Comprehensive assessment of hemorrhage risks and outcomes after stereotactic brain biopsy. J Neurosurg 94 (2001) 545-551
6. Woodworth G.F., McGirt M.J., Samdani A., Garonzik I., Olivi A., and Weingart J.D. Frameless image-guided stereotactic brain biopsy procedure: diagnostic yield, surgical morbidity, and comparison with the frame-based technique. J Neurosurg 104 (2006) 233-237
7. Lunsford L.D., Niranjan A., Khan A.A., and Kondziolka D. Establishing a benchmark for complications using frame-based stereotactic surgery. Stereotact Funct Neurosurg 86 (2008) 278-287
8. Kongkham P.N., Knifed E., Tamber M.S., and Bernstein M. Complications in 622 cases of frame-based stereotactic biopsy, a decreasing procedure. Can J Neurol Sci 35 (2008) 79-84
9. Voges J., Schroder R., Treuer H., Pastyr O., Schlegel W., Lorenz W.J., et al. CT-guided and computer assisted stereotactic biopsy. Technique, results, indications. Acta Neurochir (Wien) 125 (1993) 142-149
10. Bernstein M., and Parrent A.G. Complications of CT-guided stereotactic biopsy of intra-axial brain lesions. J Neurosurg 81 (1994) 165-168
11. Kim J.E., Kim D.G., Paek S.H., and Jung H.W. Stereotactic biopsy for intracranial lesions: reliability and its impact on the planning of treatment. Acta Neurochir (Wien) 145 (2003) 547-554 [discussion 554-545]
12. Tilgner J., Herr M., Ostertag C., and Volk B. Validation of intraoperative diagnoses using smear preparations from stereotactic brain biopsies: intraoperative versus final diagnosis-influence of clinical factors. Neurosurgery 56 (2005) 257-265 [discussion 257-265]
13. Warnick R.E., Longmore L.M., Paul C.A., and Bode L.A. Postoperative management of patients after stereotactic biopsy: results of a survey of the AANS/CNS section on tumors and a single institution study. J Neuro Oncol 62 (2003) 289-296
14. Bravo A.A., Sheth S.G., and Chopra S. Liver biopsy. N Engl J Med 344 (2001) 495-500
15. Denzer U., Helmreich-Becker I., Galle P.R., and Lohse A.W. Liver assessment and biopsy in patients with marked coagulopathy: value of mini-laparoscopy and control of bleeding. Am J Gastroenterol 98 (2003) 893-900
16. Sheela H., Seela S., Caldwell C., Boyer J.L., and Jain D. Liver biopsy: evolving role in the new millennium. J Clin Gastroenterol 39 (2005) 603-610
17. Lee H.J., and Hinrichs C.R. Is coagulopathic liver disease a factor in spontaneous cerebral hemorrhage?. J Comput Assist Tomogr 26 (2002) 69-72
18. Gronbaek H., Johnsen S.P., Jepsen P., Gislum M., Vilstrup H., Tage-Jensen U., et al. Liver cirrhosis, other liver diseases, and risk of hospitalisation for intracerebral haemorrhage: a Danish population-based case-control study. BMC Gastroenterol 8 (2008) p. 16
19. Sawin P.D., Hitchon P.W., Follett K.A., and Torner J.C. Computed imaging-assisted stereotactic brain biopsy: a risk analysis of 225 consecutive cases. Surg Neurol 49 (1998) 640-649
20. McGirt M.J., Woodworth G.F., Coon A.L., Frazier J.M., Amundson E., Garonzik I., et al. Independent predictors of morbidity after image-guided stereotactic brain biopsy: a risk assessment of 270 cases. J Neurosurg 102 (2005) 897-901
21. Paleologos T.S., Dorward N.L., Wadley J.P., and Thomas D.G. Clinical validation of true frameless stereotactic biopsy: analysis of the first 125 consecutive cases. Neurosurgery 49 (2001) 830-835 [discussion 835-837]
22. Regis J., Bouillot P., Rouby-Volot F., Figarella-Branger D., Dufour H., and Peragut J.C. Pineal region tumors and the role of stereotactic biopsy: review of the mortality, morbidity, and diagnostic rates in 370 cases. Neurosurgery 39 (1996) 907-912 [discussion 912-904]
23. Heper A.O., Erden E., Savas A., Ceyhan K., Erden I., Akyar S., et al. An analysis of stereotactic biopsy of brain tumors and nonneoplastic lesions: a prospective clinicopathologic study. Surg Neurol 64 Suppl. 2 (2005) S82-S88
24. Chernov M.F., Muragaki Y., Ochiai T., Taira T., Ono Y., Usukura M., et al. Spectroscopy-supported frame-based image-guided stereotactic biopsy of parenchymal brain lesions: comparative evaluation of diagnostic yield and diagnostic accuracy. Clin Neurol Neurosurg 111 (2009) 527-535
25. Callovini G.M., Sherkat S., Rinaldi A., Santucci N., and Gazzeri G. Stereotactic-guided microsurgical removal of lesions without cortical appearance planned by three-dimensional CT reconstruction: limits and advantages of the frame-based technique. Minim Invas Neurosurg 41 (1998) 187-193
26. Smith J.S., Quinones-Hinojosa A., Barbaro N.M., and McDermott M.W. Frame-based stereotactic biopsy remains an important diagnostic tool with distinct advantages over frameless stereotactic biopsy. J Neuro Oncol 73 (2005) 173-179